These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 24561793)

  • 1. Chronic lymphocytic leukemia nurse-like cells express hepatocyte growth factor receptor (c-MET) and indoleamine 2,3-dioxygenase and display features of immunosuppressive type 2 skewed macrophages.
    Giannoni P; Pietra G; Travaini G; Quarto R; Shyti G; Benelli R; Ottaggio L; Mingari MC; Zupo S; Cutrona G; Pierri I; Balleari E; Pattarozzi A; Calvaruso M; Tripodo C; Ferrarini M; de Totero D
    Haematologica; 2014 Jun; 99(6):1078-87. PubMed ID: 24561793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interaction between hepatocyte growth factor and its receptor (c-MET) prolongs the survival of chronic lymphocytic leukemic cells through STAT3 phosphorylation: a potential role of mesenchymal cells in the disease.
    Giannoni P; Scaglione S; Quarto R; Narcisi R; Parodi M; Balleari E; Barbieri F; Pattarozzi A; Florio T; Ferrini S; Corte G; de Totero D
    Haematologica; 2011 Jul; 96(7):1015-23. PubMed ID: 21486864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte Growth Factor: A Microenvironmental Resource for Leukemic Cell Growth.
    Giannoni P; Fais F; Cutrona G; Totero D
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30642077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
    Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
    Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
    Giannoni P; Cutrona G; Totero D
    Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular nicotinamide phosphoribosyltransferase (NAMPT) promotes M2 macrophage polarization in chronic lymphocytic leukemia.
    Audrito V; Serra S; Brusa D; Mazzola F; Arruga F; Vaisitti T; Coscia M; Maffei R; Rossi D; Wang T; Inghirami G; Rizzi M; Gaidano G; Garcia JG; Wolberger C; Raffaelli N; Deaglio S
    Blood; 2015 Jan; 125(1):111-23. PubMed ID: 25368373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoleamine 2,3-dioxygenase 1 (IDO1) activity correlates with immune system abnormalities in multiple myeloma.
    Bonanno G; Mariotti A; Procoli A; Folgiero V; Natale D; De Rosa L; Majolino I; Novarese L; Rocci A; Gambella M; Ciciarello M; Scambia G; Palumbo A; Locatelli F; De Cristofaro R; Rutella S
    J Transl Med; 2012 Dec; 10():247. PubMed ID: 23232072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.
    Fiorcari S; Martinelli S; Bulgarelli J; Audrito V; Zucchini P; Colaci E; Potenza L; Narni F; Luppi M; Deaglio S; Marasca R; Maffei R
    Haematologica; 2015 Feb; 100(2):253-62. PubMed ID: 25398834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
    Curran TA; Jalili RB; Farrokhi A; Ghahary A
    Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The paracrine immunomodulatory interactions between the human dental pulp derived mesenchymal stem cells and CD4 T cell subsets.
    Özdemir AT; Özgül Özdemir RB; Kırmaz C; Sarıboyacı AE; Ünal Halbutoğlları ZS; Özel C; Karaöz E
    Cell Immunol; 2016 Dec; 310():108-115. PubMed ID: 27576175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guilty bystanders: nurse-like cells as a model of microenvironmental support for leukemic lymphocytes.
    Filip AA; Ciseł B; Wąsik-Szczepanek E
    Clin Exp Med; 2015 Feb; 15(1):73-83. PubMed ID: 24337970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The hepatocyte growth factor antagonist NK4 inhibits indoleamine-2,3-dioxygenase expression via the c-Met-phosphatidylinositol 3-kinase-AKT signaling pathway.
    Wang D; Saga Y; Sato N; Nakamura T; Takikawa O; Mizukami H; Matsubara S; Fujiwara H
    Int J Oncol; 2016 Jun; 48(6):2303-9. PubMed ID: 27082119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q; DeFrances MC; Zarnegar R
    Cell Growth Differ; 1996 Jun; 7(6):821-32. PubMed ID: 8780895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation.
    Maffei R; Bulgarelli J; Fiorcari S; Bertoncelli L; Martinelli S; Guarnotta C; Castelli I; Deaglio S; Debbia G; De Biasi S; Bonacorsi G; Zucchini P; Narni F; Tripodo C; Luppi M; Cossarizza A; Marasca R
    Haematologica; 2013 Jul; 98(7):1115-23. PubMed ID: 23349302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the HGF receptor c-met by macrophages in experimental autoimmune encephalomyelitis.
    Moransard M; Sawitzky M; Fontana A; Suter T
    Glia; 2010 Apr; 58(5):559-71. PubMed ID: 19941340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated interleukin-27 levels in human neonatal macrophages regulate indoleamine dioxygenase in a STAT-1 and STAT-3-dependent manner.
    Jung JY; Gleave Parson M; Kraft JD; Lyda L; Kobe B; Davis C; Robinson J; Peña MM; Robinson CM
    Immunology; 2016 Sep; 149(1):35-47. PubMed ID: 27238498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells.
    Curti A; Pandolfi S; Valzasina B; Aluigi M; Isidori A; Ferri E; Salvestrini V; Bonanno G; Rutella S; Durelli I; Horenstein AL; Fiore F; Massaia M; Colombo MP; Baccarani M; Lemoli RM
    Blood; 2007 Apr; 109(7):2871-7. PubMed ID: 17164341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.
    DelaRosa O; Lombardo E; Beraza A; Mancheño-Corvo P; Ramirez C; Menta R; Rico L; Camarillo E; García L; Abad JL; Trigueros C; Delgado M; Büscher D
    Tissue Eng Part A; 2009 Oct; 15(10):2795-806. PubMed ID: 19231921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depletion of CLL-associated patrolling monocytes and macrophages controls disease development and repairs immune dysfunction in vivo.
    Hanna BS; McClanahan F; Yazdanparast H; Zaborsky N; Kalter V; Rößner PM; Benner A; Dürr C; Egle A; Gribben JG; Lichter P; Seiffert M
    Leukemia; 2016 Mar; 30(3):570-9. PubMed ID: 26522085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human regulatory macrophages are potent in suppression of the xenoimmune response via indoleamine-2,3-dioxygenase-involved mechanism(s).
    Guo F; Hu M; Huang D; Zhao Y; Heng B; Guillemin G; Lim CK; Hawthorne WJ; Yi S
    Xenotransplantation; 2017 Sep; 24(5):. PubMed ID: 28771838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.